ZA87309B - - Google Patents

Info

Publication number
ZA87309B
ZA87309B ZA87309A ZA87309A ZA87309B ZA 87309 B ZA87309 B ZA 87309B ZA 87309 A ZA87309 A ZA 87309A ZA 87309 A ZA87309 A ZA 87309A ZA 87309 B ZA87309 B ZA 87309B
Authority
ZA
South Africa
Prior art keywords
thiochroman
chroman
racemic
chiral
hydroxy
Prior art date
Application number
ZA87309A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ZA87309B publication Critical patent/ZA87309B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/322,3-Dihydro derivatives, e.g. flavanones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ZA87309A 1986-01-17 1987-01-16 ZA87309B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/000091 WO1987004344A1 (en) 1986-01-17 1986-01-17 Hydroxyacetic acid derivatives for the treatment of diabetic complications

Publications (1)

Publication Number Publication Date
ZA87309B true ZA87309B (da) 1988-07-18

Family

ID=22195340

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA87309A ZA87309B (da) 1986-01-17 1987-01-16

Country Status (26)

Country Link
US (1) US4853410A (da)
EP (1) EP0230379B1 (da)
JP (1) JPS62169775A (da)
KR (1) KR890004104B1 (da)
CN (1) CN1015545B (da)
AT (1) ATE62237T1 (da)
AU (1) AU574001B2 (da)
CA (1) CA1283119C (da)
DD (1) DD266735A5 (da)
DE (1) DE3768966D1 (da)
DK (1) DK21687A (da)
EG (1) EG18353A (da)
ES (1) ES2022319B3 (da)
FI (1) FI94636C (da)
GR (1) GR3001863T3 (da)
HU (1) HU206618B (da)
IE (1) IE59450B1 (da)
IL (1) IL81261A (da)
NO (1) NO171411C (da)
NZ (1) NZ218970A (da)
PH (2) PH22231A (da)
PL (1) PL148082B1 (da)
PT (1) PT84107B (da)
WO (1) WO1987004344A1 (da)
YU (1) YU46042B (da)
ZA (1) ZA87309B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
AU2440599A (en) * 1998-02-25 1999-09-15 Shionogi & Co., Ltd. Therapeutic agent for complication of diabetes
AT502844B1 (de) * 2005-12-12 2007-08-15 Fronius Int Gmbh Schweissbrenner und endstück sowie kontaktrohr für einen schweissbrenner
JP5654994B2 (ja) * 2008-10-02 2015-01-14 カンブレックス カルルスクーガ アクチ ボラケットCambrex Karlskoga Ab ジケトン及び薬剤を製造するための新しいプロセス
CN105924425B (zh) * 2016-04-29 2018-06-05 浙江师范大学 一种制备二氢硫色满衍生物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359161A (en) * 1963-08-29 1967-12-19 Kefalas As Thiaxanthenols, process of producing and anti-tussive compositions thereof
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4210663A (en) * 1978-11-08 1980-07-01 Pfizer Inc. Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
ATE11781T1 (de) * 1981-05-13 1985-02-15 Imperial Chemical Industries Plc Pharmazeutische zubereitungen, die spirosuccinimidderivate enthalten.
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds

Also Published As

Publication number Publication date
JPH0586952B2 (da) 1993-12-14
NO873854L (no) 1987-09-15
CN1015545B (zh) 1992-02-19
CN87100191A (zh) 1987-09-09
US4853410A (en) 1989-08-01
FI873843A (fi) 1987-09-04
IL81261A0 (en) 1987-08-31
PL148082B1 (en) 1989-09-30
HU206618B (en) 1992-12-28
KR870007149A (ko) 1987-08-17
CA1283119C (en) 1991-04-16
ES2022319B3 (es) 1991-12-01
NZ218970A (en) 1988-11-29
WO1987004344A1 (en) 1987-07-30
FI873843A0 (fi) 1987-09-04
IE870131L (en) 1987-07-17
NO171411B (no) 1992-11-30
PT84107A (en) 1987-02-01
EG18353A (en) 1993-02-28
IL81261A (en) 1992-05-25
NO171411C (no) 1993-03-10
DD266735A5 (de) 1989-04-12
DK21687D0 (da) 1987-01-16
YU5787A (en) 1988-04-30
PT84107B (pt) 1989-07-31
PH24703A (en) 1990-10-01
FI94636B (fi) 1995-06-30
DE3768966D1 (de) 1991-05-08
EP0230379B1 (en) 1991-04-03
AU574001B2 (en) 1988-06-23
JPS62169775A (ja) 1987-07-25
FI94636C (fi) 1995-10-10
NO873854D0 (no) 1987-09-15
PH22231A (en) 1988-07-01
DK21687A (da) 1987-07-18
KR890004104B1 (ko) 1989-10-20
HUT48230A (en) 1989-05-29
YU46042B (sh) 1992-12-21
ATE62237T1 (de) 1991-04-15
PL263678A1 (en) 1988-04-14
EP0230379A3 (en) 1988-10-05
AU6764187A (en) 1987-07-30
IE59450B1 (en) 1994-02-23
GR3001863T3 (en) 1992-11-23
EP0230379A2 (en) 1987-07-29

Similar Documents

Publication Publication Date Title
CS29990A3 (en) Racemic or optically active bis-aza-bicyclic compounds, process forpreparing thereof, intermediates and use
GB8806737D0 (en) Therapeutic composition & method
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
HUT54345A (en) Process for producing new, antiarrhythmic, sulfur-containing cyanophenol derivatives and medical compositions comprising same
GR3001863T3 (en) Chroman- and thiochroman-4-acetic acids useful in the treatment of diabetic complications
HUT55990A (en) Process for producing pharmaceutical compositions containing optically pure r-(-)-niguldipine and derivatives utilizable for treating tumors
AU3709289A (en) Strontium salt
GR3025530T3 (en) Antihypertensive benzopyran derivatives
NO169717C (no) Fremgangsmaate for fremstilling av et stabilt hydrat av etpenicillinderivat.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
AU7719491A (en) Therapeutic compound
ATE46908T1 (de) Verfahren zur herstellung von 4,5-dihydrodithieno(3,4b:3',4'-e>-azepin-5,9-dion.
EP0351017A3 (en) Pharmaceutical composition useful for the treatment of cardiovascular diseases
AU3489889A (en) Tryptophan for treatment of coughing
HU904166D0 (en) Process for producing (+)-(2s,3s)-3-hydroxi-2-(4-methoxy-phenyl)-2,3-dihydro-5h-1,5-benzotriazepine-4-one derivatives
AU4871490A (en) Method of treatment using 18-cyanoprogesterone derivatives
IE880151L (en) Method for treatment of hyperacidity.